Review: taking Phenytoin and Vimpat together


Summary

Drug interactions are reported among people who take Phenytoin and Vimpat together. This review analyzes the effectiveness and drug interactions between Phenytoin and Vimpat. It is created by eHealthMe based on reports of 754 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Phenytoin

Phenytoin has active ingredients of phenytoin. It is often used in convulsion. (latest outcomes from Phenytoin 12,315 users)

Vimpat

Vimpat has active ingredients of lacosamide. It is often used in epilepsy. (latest outcomes from Vimpat 6,057 users)

On Sep, 15, 2016

754 people who take Phenytoin, Vimpat are studied.


Number of reports submitted per year:

Phenytoin and Vimpat drug interactions.

Drug effectiveness over time:

Phenytoin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Vimpat:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Phenytoin:
  • female: 0.0% - (0 of 2 people)
  • male: 0.0% - (0 of 1 people)
Vimpat:
  • female: 0.0% - (0 of 2 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Phenytoin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 1 people)
Vimpat:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • pyrexia
  • convulsion
  • vision blurred
  • diplopia
  • overdose
  • sudden death
  • agitation
  • seizure
  • blood pressure decreased
  • drug ineffective
1 - 6 months:
  • convulsion
  • status epilepticus
  • drug ineffective
  • cleft lip and palate
  • confusional state
  • limb malformation
  • microcephaly
  • spina bifida
  • dizziness
  • encephalopathy
6 - 12 months:
  • overdose
  • seizure
  • complex partial seizures
  • nausea
  • neutropenia
  • stress
  • vomiting
  • abdominal pain upper
  • anticonvulsant drug level increased
  • balance disorder
1 - 2 years:
  • seizure
  • convulsion
  • fall
  • head injury
  • status epilepticus
  • affect lability
  • amnesia
  • aphasia
  • asthenia
  • calcinosis
2 - 5 years:
  • bruxism
  • catatonia
  • erectile dysfunction
  • atrial fibrillation
  • atrial flutter
  • atrioventricular block first degree
  • cardiac hypertrophy
  • cerebrovascular accident
  • drug screen positive
  • hypertension
5 - 10 years:
  • anticonvulsant drug level decreased
  • bronchitis
  • cerebrovascular accident
  • coma
  • convulsion
  • dementia
  • emotional disorder
  • headache
  • influenza
  • lung cancer metastatic
10+ years:
  • convulsion
  • status epilepticus
  • toxic encephalopathy
  • anticonvulsant drug level abnormal
  • coma
  • drug level fluctuating
  • dysuria
  • fall
  • hemiplegia
  • hypoaesthesia
not specified:
  • convulsion
  • seizure
  • diplopia
  • drug ineffective
  • balance disorder
  • neurotoxicity
  • dizziness
  • status epilepticus
  • somnolence
  • fatigue

Most common drug interactions by gender *:

female:
  • convulsion
  • balance disorder
  • diplopia
  • dizziness
  • neurotoxicity
  • seizure
  • drug ineffective
  • somnolence
  • status epilepticus
  • anticonvulsant drug level decreased
male:
  • convulsion
  • seizure
  • drug ineffective
  • status epilepticus
  • diplopia
  • confusional state
  • vision blurred
  • anger
  • fatigue
  • overdose

Most common drug interactions by age *:

0-1:
  • drug ineffective
  • stevens-johnson syndrome
  • toxic epidermal necrolysis
  • cardiopulmonary failure
  • convulsion
  • disease progression
  • infantile spasms
  • partial seizures
  • pneumonitis
2-9:
  • irritability
  • anger
  • crying
  • depressed mood
  • drooling
  • head banging
  • hypophagia
  • oral discomfort
  • pyrexia
  • abnormal behaviour
10-19:
  • convulsion
  • drug ineffective
  • seizure
  • aphasia
  • cerebral atrophy
  • drug toxicity
  • dyspnoea
  • erythema multiforme
  • facial bones fracture
  • grand mal convulsion
20-29:
  • seizure
  • overdose
  • hypotension
  • convulsion
  • drug ineffective
  • pregnancy
  • ileus
  • fatigue
  • headache
  • somnolence
30-39:
  • balance disorder
  • diplopia
  • convulsion
  • neurotoxicity
  • drug ineffective
  • dizziness
  • anticonvulsant drug level decreased
  • status epilepticus
  • seizure
  • somnolence
40-49:
  • vision blurred
  • diplopia
  • convulsion
  • confusional state
  • drug level fluctuating
  • cerebrovascular accident
  • transient ischaemic attack
  • weight decreased
  • seizure
  • anticonvulsant drug level abnormal
50-59:
  • convulsion
  • status epilepticus
  • overdose
  • seizure
  • tremor
  • fall
  • drug ineffective
  • grand mal convulsion
  • disorientation
  • head injury
60+:
  • convulsion
  • drug ineffective
  • seizure
  • confusional state
  • anger
  • anticonvulsant drug level decreased
  • fall
  • complex partial seizures
  • hallucination
  • laryngeal injury

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Phenytoin and Vimpat?

Can you answer these questions?

More questions for: Phenytoin, Vimpat

You may be interested in these reviews

More reviews for: Phenytoin, Vimpat

On eHealthMe, Phenytoin (phenytoin) is often used to treat convulsion. Vimpat (lacosamide) is often used to treat epilepsy. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.